spacer
home > pmps > spring 2018 > supply network
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Supply Network

In an industry where the entire supply chain is faced with the regulatory requirement for serialisation and traceability, the solution needs large-scale integration and interoperability. For pharmaceutical businesses, the biggest challenge is how they orchestrate project implementation both internally and externally. In the Global Drug, Supply, Safety and Traceability report, just 48% of CMOs have integrated with a majority of brand owners, and just 41% of respondents stated that a high percentage of their internal packaging lines are ready for serialisation (1).

In every business, project leads must consider the overall complexity and scale of serialisation and traceability. They must understand and update internal processes and engage external partners before specifying and implementing a strategy and solution. While the pharma sector is well-versed at improving the performance of manufacturing and packing lines with new hardware and site-level systems, integrating with partners, each with their own policies and priorities, on the scale required by global serialisation and traceability is a completely new challenge. To complicate matters, the solution cannot be stationary – new products, partners, markets and regulations, customer requirements, and opportunities keep coming.

Managing all of these is hard work, but three core pillars of serialisation and traceability integration and interoperability in product supply networks can lead to success.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Pasi Kemppainen is the Principal Advisor on pharma digitalisation at Epista Life Science. He is currently leading Santen Pharmaceutical’s global serialisation and traceability programme. Prior to Epista Life Science, Pasi worked as Senior Consultant and Advisor for NNE – a Novo Nordisk engineering and consulting company. He also served as CEO at Original1 (a joint venture of SAP, Nokia, and Giesecke & Devrient – leaders in enterprise IT, mobile, and security), servicing a cloud and mobile platform for product serialisation, traceability, and consumer authentication services in Europe and China.
spacer
Pasi Kemppainen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

c-LEcta signs Europe sales and distribution agreement with VWR for c-LEcta’s DENARASE®

• DENARASE® is now available through VWR’s sales channels in Europe • VWR, part of Avantor, is a leading global provider of product and service solutions to laboratory and production customers • Cooperation harbors the potential for c-LEcta’s product to gain additional share in a highly dynamic market
More info >>

White Papers

Digital Transformation of the Cold Chain

Sensitech EMEA

The Life Sciences cold chain is a seamless and interconnected global network of people, equipment, data and processes that helps to ensure the safety and integrity of our medicines and vaccines. Cold chain logistics spending totaled $13 billion in 2017, an investment designed to protect some $283 billion in Life Sciences cold chain products, growing at 19% annually.1 Sensitech Inc., a part of UTC Climate, Controls & Security, a unit of United Technology Corp., has played an essential part in the Life Sciences cold chain since 1990, providing a comprehensive set of solutions for manufacturers of biologics, prescription pharmaceuticals, clinical trial materials, and over-the-counter drugs. These solutions help to ensure product quality, patient safety, and regulatory compliance while helping to prevent theft and optimizing cold chain performance.
More info >>

 
Industry Events

10th Annual NGS & Clinical Diagnostics Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 10thAnnual NGS & Clinical Diagnostics Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement